These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 30910990)

  • 1. New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter.
    Leclair V; Lundberg IE
    Curr Rheumatol Rep; 2018 Mar; 20(4):18. PubMed ID: 29550929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroups.
    Giannini M; Debrut L; Nespola B; Velten M; Geny B; Sibilia J; Meyer A
    Nat Rev Rheumatol; 2024 May; 20(5):311-312. PubMed ID: 38514811
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to: Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroups.
    Khoo T; Lilleker JB; Thong BY; Leclair V; Lamb JA; Chinoy H
    Nat Rev Rheumatol; 2024 May; 20(5):313-314. PubMed ID: 38514812
    [No Abstract]   [Full Text] [Related]  

  • 4. Antisynthetase syndrome.
    Johnston G
    Clin Med (Lond); 2017 Dec; 17(6):591. PubMed ID: 29196375
    [No Abstract]   [Full Text] [Related]  

  • 5. Polymyositis with antisynthetase syndrome presented with lobular panniculitis: A case report.
    Rungcharunthanakul A; Sampattavanich N
    Clin Case Rep; 2019 Jan; 7(1):128-130. PubMed ID: 30656025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course.
    Cavagna L; Trallero-Araguás E; Meloni F; Cavazzana I; Rojas-Serrano J; Feist E; Zanframundo G; Morandi V; Meyer A; Pereira da Silva JA; Matos Costa CJ; Molberg O; Andersson H; Codullo V; Mosca M; Barsotti S; Neri R; Scirè C; Govoni M; Furini F; Lopez-Longo FJ; Martinez-Barrio J; Schneider U; Lorenz HM; Doria A; Ghirardello A; Ortego-Centeno N; Confalonieri M; Tomietto P; Pipitone N; Rodriguez Cambron AB; Blázquez Cañamero MÁ; Voll RE; Wendel S; Scarpato S; Maurier F; Limonta M; Colombelli P; Giannini M; Geny B; Arrigoni E; Bravi E; Migliorini P; Mathieu A; Piga M; Drott U; Delbrueck C; Bauhammer J; Cagnotto G; Vancheri C; Sambataro G; De Langhe E; Sainaghi PP; Monti C; Gigli Berzolari F; Romano M; Bonella F; Specker C; Schwarting A; Villa Blanco I; Selmi C; Ceribelli A; Nuno L; Mera-Varela A; Perez Gomez N; Fusaro E; Parisi S; Sinigaglia L; Del Papa N; Benucci M; Cimmino MA; Riccieri V; Conti F; Sebastiani GD; Iuliano A; Emmi G; Cammelli D; Sebastiani M; Manfredi A; Bachiller-Corral J; Sifuentes Giraldo WA; Paolazzi G; Saketkoo LA; Giorgi R; Salaffi F; Cifrian J; Caporali R; Locatelli F; Marchioni E; Pesci A; Dei G; Pozzi MR; Claudia L; Distler J; Knitza J; Schett G; Iannone F; Fornaro M; Franceschini F; Quartuccio L; Gerli R; Bartoloni E; Bellando Randone S; Zampogna G; Gonzalez Perez MI; Mejia M; Vicente E; Triantafyllias K; Lopez-Mejias R; Matucci-Cerinic M; Selva-O'Callaghan A; Castañeda S; Montecucco C; Gonzalez-Gay MA
    J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31752231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisynthetase antibodies in clinical laboratories: the importance of clinical correlation and indirect immunofluorescence. Response to: Comment on: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria' by Greco
    Greco M; García de Yébenes MJ; Alarcón I; Brandy-García AM; Rúa-Figueroa Í; Loza E; Carmona L
    Ann Rheum Dis; 2020 Jul; 79(7):e87. PubMed ID: 31167759
    [No Abstract]   [Full Text] [Related]  

  • 8. Antisynthetase syndrome - much more than just a myopathy.
    Opinc AH; Makowska JS
    Semin Arthritis Rheum; 2021 Feb; 51(1):72-83. PubMed ID: 33360231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of Pulmonary Function in a Cohort of Patients with Interstitial Lung Disease and Positive for Antisynthetase Antibodies.
    González-Pérez MI; Mejía-Hurtado JG; Pérez-Román DI; Buendía-Roldán I; Mejía M; Falfán-Valencia R; Mateos-Toledo HN; Rojas-Serrano J
    J Rheumatol; 2020 Mar; 47(3):415-423. PubMed ID: 31203227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and adverse effects of methotrexate compared with azathioprine in the antisynthetase syndrome.
    Casal-Dominguez M; Pinal-Fernandez I; Huapaya J; Albayda J; Paik JJ; Johnson C; Silhan L; Mammen AL; Danoff SK; Christopher-Stine L
    Clin Exp Rheumatol; 2019; 37(5):858-861. PubMed ID: 31074729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review.
    Saygin D; Glaubitz S; Zeng R; Bottai M; de Visser M; Dimachkie MM; Fiorentino D; Gerhardson I; Kuwana M; Miller FW; Needham M; Rider LG; Salem Y; Schlüter S; Shinjo SK; Wang G; Werth VP; Aggarwal R; Lundberg IE
    Clin Exp Rheumatol; 2024 Feb; 42(2):403-412. PubMed ID: 38436279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-synthetase syndrome associated interstitial lung disease after combination dual immune checkpoint inhibition.
    Bell PT; Beaton T; Terrill M; Gillis D; Goddard J
    Respirol Case Rep; 2023 Apr; 11(4):e01115. PubMed ID: 36923607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multidisciplinary approach to the diagnosis of antisynthetase syndrome.
    Wells M; Alawi S; Thin KYM; Gunawardena H; Brown AR; Edey A; Pauling JD; Barratt SL; Adamali HI
    Front Med (Lausanne); 2022; 9():959653. PubMed ID: 36186825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Rituximab in Korean Patients with Refractory Inflammatory Myopathies.
    Ahn GY; Suh CH; Kim YG; Park YB; Shim SC; Lee SH; Lee SS; Bae SC; Yoo DH
    J Korean Med Sci; 2020 Sep; 35(38):e335. PubMed ID: 32989931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Classification of idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific antibodies].
    Zheng S; Chen S; Wu L; Zhao D; Chen F; Zhu J; Li J
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jul; 40(7):1029-1035. PubMed ID: 32895158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria.
    To F; Parker MJS; Ventín-Rodríguez C; Lilleker JB; Chinoy H
    Rheumatology (Oxford); 2019 Dec; 58(12):2331-2333. PubMed ID: 31382296
    [No Abstract]   [Full Text] [Related]  

  • 17. Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria.
    Greco M; García de Yébenes MJ; Alarcón I; Brandy-García AM; Rúa-Figueroa Í; Loza E; Carmona L
    Ann Rheum Dis; 2019 Sep; 78(9):1291-1292. PubMed ID: 30910990
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
    Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
    JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.
    Troyanov Y; Targoff IN; Tremblay JL; Goulet JR; Raymond Y; Senécal JL
    Medicine (Baltimore); 2005 Jul; 84(4):231-249. PubMed ID: 16010208
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.